Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer
Conditions: Locally Advanced Colorectal Carcinoma Interventions: Drug: Cadonilimab; Drug: FOLFOX regimen Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Carcinoma | China Health | Colorectal Cancer | Hospitals | Neoadjuvant Therapy | Research